Captaru
  • Subventions
  • Bénévoles
  • Communauté
  • Tarifs
  • À propos
    Qui sommes-nousNos partenairesEmplois
  • Transparence
  • Contact
Captaru Logo

En partant de ce que nous pouvons faire et penser, notre force est de concrétiser des projets sociaux propres et de tiers.

proyectos@captaru.org
CAPTARU
  • À PROPOS
  • PROJETS
  • Gestion des subventions
  • Plateforme pour ONG
  • Fonds européens
  • TRANSPARENCE
  • CONTACT
SUIVEZ-NOUS
  • Facebook
  • Twitter
  • LinkedIn
  • Youtube
REJOIGNEZ NOTRE NEWSLETTER ET NE MANQUEZ AUCUNE OPPORTUNITÉ
Mentions légalesAvertissementPolitique de cookiesDéclaration de confidentialité

Fundación Plaza de Castilla, CIF G84070945, dont le siège est situé Serrano Anguita 13, 28004 Madrid.

CAPTARU EST UN PROJET DÉVELOPPÉ AVEC PASSION PAR LA FUNDACIÓN PLAZA DE CASTILLA © 2026 TOUS DROITS RÉSERVÉS

Démarrer une proposition avec Captaru
🇺🇸GRANTS_GOVOUVERTGRANT47 jours restants

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)

🏛 GRANTS_GOV · 📍 US

Budget total

Non spécifié

OUVERTURE

5/11/2024

CLÔTURE

28/9/2026

Categoría

Education / Health / Income Security and Social Services

Description

The purpose of this announcement is to encourage investigators to pursue a small clinical trial to obtain critical information necessary to advance recording and/or stimulating devices to treat central nervous system disorders and better understand the human brain (e.g., Early Feasibility Study). Clinical studies supported may consist of acute or short-term procedures that are deemed Non-Significant Risk (NSR) by an Institutional Review Board (IRB), or Significant Risk (SR) studies that require an Investigational Device Exemption (IDE) from the FDA, such as chronic implants. The clinical trial should provide data to answer key questions about the function or final design of a device. This final device design may require most, if not all, of the non-clinical testing on the path to more advanced clinical trials and market approval. The clinical trial is expected to provide information that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. Activities supported by this Funding Opportunity include a small clinical trial to answer key questions about the function or final design of a device.As part of the BRAIN Initiative, NIH has initiated a Public-Private Partnership Program (BRAIN PPP) that includes agreements (Memoranda of Understanding, MOU) with a number of device manufacturers willing to make such devices available, including devices and capabilities not yet market approved but appropriate for clinical research. In general it is expected that the devices' existing safety and utility data will be sufficient to enable new IRB NSR or FDA IDE approval without need for significant additional non-clinical data. For more information on the BRAIN PPP, see http://braininitiative.nih.gov/BRAIN_PPP/index.htm

Source officielle

Voir la source officielle ↗

Beneficiarios elegibles

  • City or township governments
  • Others (see text field entitled "Additional Information on Eligibility" for clarification)
  • Native American tribal organizations (other than Federally recognized tribal governments)
  • Small businesses
  • Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
  • Independent school districts
  • Public housing authorities/Indian housing authorities
  • Public and State controlled institutions of higher education
  • Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
  • State governments
  • Private institutions of higher education
  • County governments
  • For profit organizations other than small businesses
  • Native American tribal governments (Federally recognized)
  • Special district governments

Appels similaires

  • BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
  • Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
  • Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
  • BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)
  • BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
  • New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
Voir toutes les subventions ouvertes